On Friday, the US Supreme Court granted review in two IP cases:

• Amgen Inc. v. Sanofi – on patent enablement and whether the full scope of the patent has to be enabled.
• Abitron Austria GmbH v. Hetronic International – on the scope of the Lanham Act on extraterritorial sales that never reach the United States or confuse US consumers.